Natalizumab for the prevention of post-partum relapses in women with multiple sclerosis

Multiple Sclerosis

Volumn 21, Issue 7, 2015, Pages 953-955

  Vukusic, Sandra ^b,c,d   Durand Dubief, Françoise ^a   Benoit, Amandine ^a   Marignier, Romain ^b,c,d   Frangoulis, Bernard ^b,c,d   Confavreux, Christian ^b,c,d  

^a HÔPITAL NEUROLOGIQUE   (France)

^b LYON NEUROSCIENCE RESEARCH CENTER   (France)

^c UNIVERSITÉ DE LYON   (France)

^d UNIVERSITÉ LYON 1   (France)

Author keywords

Multiple sclerosis; natalizumab; post partum; pregnancy; relapses

Indexed keywords

NATALIZUMAB; IMMUNOLOGIC FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; DELIVERY; DISEASE ACTIVITY; FEMALE; HIGH RISK PATIENT; HUMAN; MULTIPLE SCLEROSIS; PREGNANCY; PUERPERIUM; RECURRENCE RISK; RETROSPECTIVE STUDY; SECONDARY PREVENTION; DRUG EFFECTS; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PREGNANCY COMPLICATIONS; RECURRENT DISEASE;

ADULT; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NATALIZUMAB; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS; RECURRENCE; RETROSPECTIVE STUDIES;

EID: 84930398080     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458514554056     Document Type: Article

References (10)

1. Confavreux C, Hutchinson M, Hours MM, et al. Rate of pregnancy-related relapse in multiple sclerosis. N Engl J Med. 1998; 339: 285-291
2. Lu E, Wang BW, Guimond C, et al. Disease-modifying drugs for multiple sclerosis in pregnancy: A systematic review. Neurology. 2012; 79: 1130-1135
3. Killestein J, Vennegoor A, Strijbis EM, et al. Natalizumab drug holiday in multiple sclerosis: Poorly tolerated. Ann Neurol. 2010; 68: 392-395
4. Vukusic S, Hutchinson M, Hours M, et al. Pregnancy and multiple sclerosis (the PRIMS study): Clinical predictors of post-partum relapse. Brain. 2004; 127: 1353-1360
5. Achiron A, Kishner I, Dolev M, et al. Effect of intravenous immunoglobulin treatment on pregnancy and post-partum related relapses in multiple sclerosis. J Neurol. 2004; 251: 1133-1137
6. Haas J, Hommes OR.. A dose comparison study of IVIG in postpartum relapsing-remitting multiple sclerosis. Mult Scler. 2007; 13: 900-908
7. De Sèze J, Chapelotte M, Delalande S, et al. Intravenous corticosteroids in the postpartum period for reduction of acute exacerbations in multiple sclerosis. Mult Scler. 2004; 10: 596-597
8. Vukusic S, Ionescu I, El-Etr M, et al. The Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple Sclerosis (POPART'MUS) trial: Rationale, objectives and state of advancement. J Neurol Sci. 2009; 286: 114-118
9. Miller DH, Khan OA, Sheremata WA, et al. A controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med. 2003; 348: 15-23
10. Hellwig K, Haghikia A, Gold R.. Pregnancy and natalizumab: Results of an observational study in 35 accidental pregnancies during natalizumab treatment. Mult Scler. 2011; 17: 958-963